{
    "Trade/Device Name(s)": [
        "BBLTM CHROMagarTM MRSA II"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K092767",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042812",
        "K863821"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JSO"
    ],
    "Summary Letter Date": "August 18, 2010",
    "Summary Letter Received Date": "August 19, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.1700"
    ],
    "Regulation Name(s)": [
        "Culture Medium for Antimicrobial Susceptibility Tests"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA)"
    ],
    "Specimen Type(s)": [
        "Anterior nares swab"
    ],
    "Specimen Container(s)": [
        "Swab"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromogenic selective and differential culture medium"
    ],
    "Methodologies": [
        "Culture",
        "Antimicrobial susceptibility testing",
        "Chromogenic detection"
    ],
    "Submission Type(s)": [
        "Medium"
    ],
    "Document Summary": "FDA 510(k) summary for BBL CHROMagar MRSA II selective chromogenic medium for direct detection of MRSA nasal colonization from nares swabs",
    "Indications for Use Summary": "Qualitative direct detection of nasal colonization by MRSA using anterior nares swab specimens to aid prevention and control of MRSA infections in healthcare settings",
    "fda_folder": "Microbiology"
}